DNTH - Dianthus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNTH is currently covered by 11 analysts with an average price target of $140.45. This is a potential upside of $48.79 (53.23%) from yesterday's end of day stock price of $91.66.

Dianthus Therapeutics's activity chart (see below) currently has 34 price targets and 60 ratings on display. The stock rating distribution of DNTH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.79% with an average time for these price targets to be met of 289.7 days.

Highest price target for DNTH is $200, Lowest price target is $65, average price target is $121.9.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 12-Mar-2026. First documented stock forecast 28-Sep-2023.

Currently out of the existing stock ratings of DNTH, 33 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Nov-2023

$103

$17 (19.77%)

$80

29 days ago
(12-Mar-2026)

12/13 (92.31%)

$22.68 (28.24%)

165

Buy Since 28-Sep-2023

$123

$37 (43.02%)

$56

1 months ago
(10-Mar-2026)

3/4 (75%)

$36.08 (41.51%)

419

Buy Since 26-Jul-2024

$132

$46 (53.49%)

1 months ago
(10-Mar-2026)

3/4 (75%)

$45.08 (51.86%)

452

Buy Since 16-Sep-2025

$130

$44 (51.16%)

$100

1 months ago
(10-Mar-2026)

0/2 (0%)

$43.08 (49.56%)

Buy Since 16-May-2024

$130

$44 (51.16%)

$47

1 months 1 days ago
(09-Mar-2026)

8/9 (88.89%)

$50.77 (64.08%)

295

Show more analysts

Please expand the browser size to see the chart

What is DNTH (Dianthus Therapeutics) average time for price targets to be met?

On average it took 289.7 days on average for the stock forecasts to be realized with a an average price target met ratio 69.79

Which analyst has the current highest performing score on DNTH (Dianthus Therapeutics) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?

Yatin Suneja works at GUGGENHEIM and has 6 price targets and 8 ratings on DNTH

Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?

Yatin Suneja with highest potential upside - $114

Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?

Alex Thompson with lowest potential downside - -$21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?